cardiomyopathies andre keren, md דר ' ישראל גוטסמן מערך הלב, הדסה...
TRANSCRIPT
![Page 1: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/1.jpg)
CardiomyopathiesAndre Keren, MD
גוטסמן' ישראל דר , כרם עין הדסה הלב מערך
![Page 2: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/2.jpg)
Cardiomyopathies
• Cardiomyopathies: Heart muscle disease• A myocardial disorder in which the heart
muscle is structurally and functionally abnormal in the absence of:
coronary artery disease, hypertension, valvular disease and congenital heart disease
![Page 3: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/3.jpg)
Cardiomyopathies
• Dilated CM (DCM)
• Hypertrophic CM (HCM)
• Restrictive CM (RCM)
• Arrhythmogenic RV dysplasia (ARVD)
![Page 4: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/4.jpg)
Classification of Cardiomyopathies
Dilated RestrictiveArrhythmogenic RV dysplasia
Hypertrophic
![Page 5: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/5.jpg)
Dilated CM(DCM)
Hypertrophic CM(HCM)
Restrictive CM(RCM)
Normal
![Page 6: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/6.jpg)
מורחבת היפרטרופיתרסטריקטיבי
ת
חלל החדר גודל + + / - N N- /
החדר התכווצות - - + + N- /
השריר עובי N- / + + / +N
ממצאים מורפולוגיים
![Page 7: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/7.jpg)
מורחבת היפרטרופיתרסטריקטיבי
ת
האי סיבתלב ספיקת
סיסטולית דיאסטולית דיאסטולית
המוות סיבתהעיקרית
, לב ספיקת איפתאומי מוות
פתאומי מוות, משתנה פרוגנוזה
לב ספיקת אי
קליניקה עיקרית
![Page 8: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/8.jpg)
Pathogenesis
![Page 9: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/9.jpg)
SarcomereBasic Unit of The Muscle
![Page 10: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/10.jpg)
Genetics of CMP
Genes encoding: Cytoskeletal proteins – DCM:• Beta/delta-sarcoglycan• Dystrophin • desmin and lamin A/C
(intermediate filament)Sarcomeric proteins – DCM/HCM:• Actin• b-myosin heavy chain• a-tropomyosin• cardiac troponin THCM:• cardiac troponin I• titin • myosin light chains
![Page 11: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/11.jpg)
Genetics of CMP
![Page 12: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/12.jpg)
Genetics of CMP
Functional alterations caused by Z-disc mutations
HCM
DCM
![Page 13: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/13.jpg)
Hypertrophic Cardiomyopathy (HCM)
![Page 14: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/14.jpg)
Hypertrophic Cardiomyopathy (HCM)
• Most common genetic cardiovascular disease
• Prevalence 0.2% (1:500) • Autosomal dominant trait • Gene mutations of cardiac sarcomere
proteins• 18 genes and >500 individual mutations
have been identified…
![Page 15: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/15.jpg)
Spirito P, Seidman CE, McKenna WJ, Maron BJ. NEJM 1997;336:775
Genetic Mutations in HCM
![Page 16: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/16.jpg)
Major Mutations in HCM:Risk of sudden death
• Beta myosin heavy chain (35%): Typical features, both malignant and benign types
• Myosin binding protein C (15%):
Late appearance, usually benign• Troponin T (15%):
Mild hypertrophy, malignant
![Page 17: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/17.jpg)
Non-Sarcomeric mutations that causeStorage diseases and mimic LV Hypertophy
• Anderson-Fabry disease: X-linked lysosomal storage disease ( -a galactosidase A)
• PRKAG2 mutation
Glycogen accumulation
• Danon disease: LAMP2 mutation X-linked
Massive hypertrophy,
preexitation,
malignant prognosis
![Page 18: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/18.jpg)
Hypertrophic Cardiomyopathy (HCM)
LVHypertrophyLVOT
obstruction
![Page 19: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/19.jpg)
HCM
SEPTUM LV
AO
LV Hypertrophy
![Page 20: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/20.jpg)
Natural History of LV Hypertrophy
Increase in LV hypertrophy after adolescence
![Page 21: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/21.jpg)
HCM - Histopathology
Normal
• Myocardial Disarray
• Fibrosis
Small-vessel disease: Remodeled intramural coronary arteriole with thickened media and narrowed lumen
![Page 22: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/22.jpg)
SAMSystolic Anterior
Motion of MV
LVOT obstructionLeft Ventricular Outflow Obstruction (Dynamic)
Pathophysiology
Mitral Regurgitation
ASHAsymmetric septal
hypertrophy
Mitral valve Abnormalities
Diastolic dysfunction
![Page 23: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/23.jpg)
Clinical Presentation
• Sudden death – ventricular tachyarrhythmias• Asymptomatic• Chest Pain• Limited functional capacity• Progressive heart failure• Embolic stroke
![Page 24: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/24.jpg)
Symptoms• Exertional dyspnea, Exercise intolerance• Fatigue • Chest pain• Syncope
Pathophysiology • LV outflow obstruction - elevated LV
pressures and wall stress• Diastolic dysfunction - impaired LV filling due
to noncompliant and thickened wall• Myocardial ischemia from the small vessel
disease
![Page 25: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/25.jpg)
Diagnosis
• Examination: Characteristic findings• ECG: LVH• Echo: Most useful diagnostic tool• ECG Holter: Arrhythmias• Stress test: Blood pressure response• Catheterization: rule out associated CAD
![Page 26: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/26.jpg)
Triple
BisferiensLVOT
MR
4
Physical findings in HOCM
![Page 27: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/27.jpg)
![Page 28: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/28.jpg)
Maneuvers and HOCM Murmur
Murmur increase:• Valsalva maneuver• Exercise• Standing
![Page 29: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/29.jpg)
ECG in HCM
LVH, ST-T changes, T wave inversion
• Abnormal in 90% of patients
![Page 30: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/30.jpg)
Echocardiography in HCM
LVH, ASH, SAM, MR
![Page 31: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/31.jpg)
Natural History of HCM
![Page 32: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/32.jpg)
Mortality in HCMHigher in younger patients - SCD
![Page 33: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/33.jpg)
Functional Capacity and SCD
![Page 34: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/34.jpg)
Causes of SCD in young athletes
HCM is the major cause of SCD in young & in athletes
![Page 35: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/35.jpg)
LV Hypertrophy and SCD
Significant increase in SCD risk if Max Wall thickness >30mm
![Page 36: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/36.jpg)
Risk Factors:
• Cardiac arrest/sustained VT
• Multiple familial SD• Unexplained syncope• Massive LVH (>3cm)
• Multiple-repetitive NSVT• Abnormal blood pressure on
exercise
• Malignant genotype (troponinT)• End stage disease• Extensive delayed enhancement on MRI• Marked LVOT outflow obstruction (rest)
Highest(>2)
Intermediate(1)
Lowest(0)
ICD
?
Risk Stratification
11%/yr
4%/yr
![Page 37: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/37.jpg)
Therapy
• Reduce LVOT obstruction• Alleviate elevated diastolic pressures• Reduce microvascular ischemia
Beta Blockers, Verapamil, Disopyramide
• Atrial Fibrillation
Amiodorone, Anticoagulants
• Heart Failure
HF therapy
![Page 38: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/38.jpg)
Therapy
Interventions to reduce LVOT obstruction: • Pacemaker (DDD): Reduces obstruction
• Alcohol septal ablation• Surgical myomectomy
![Page 39: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/39.jpg)
Nishimura RA. NEJM 2004;350:1320-7
Septal Myomectomy in HOCM
![Page 40: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/40.jpg)
NEJM 347:1307,2002A. Keren
Septal Ablation in HOCM
![Page 41: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/41.jpg)
Septal Ablation in HOCM Acute Hemodynamic Result
![Page 42: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/42.jpg)
Dilated Cardiomyopathy (DCM)
Normal Heart Dilated Cardiomyopathy (DCM)
![Page 43: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/43.jpg)
Dilated Cardiomyopathy (DCM)
![Page 44: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/44.jpg)
Dilated Cardiomyopathy (DCM)
• Myocarditis: Viral/ Inflammatory• Idiopathic (50%)• Genetic
![Page 45: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/45.jpg)
Dilated Cardiomyopathy (DCM)
• Sensitivity and toxins: alcohol, catecholamines, anthracyclines, irradiation
• Metabolic cardiomyopathy: endocrine abnormalities, glycogen storage disease, deficiencies (hypokalemia), and nutritional disorders
• General systemic disease: connective tissue disorders and infiltrative diseases: sarcoidosis and leukemia
• Muscular dystrophies: Duchenne, Becker-type, myotonic dystrophies
• Neuromuscular disorders: Friedreich ataxia, Noonan syndrome, lentiginosis
![Page 46: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/46.jpg)
Dilated Cardiomyopathy (DCM)
• Peripartum• Tachycardia-mediated• Sarcoidosis
![Page 47: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/47.jpg)
![Page 48: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/48.jpg)
Dilated Cardiomyopathy (DCM)Familial
Genetic (~50%):• Family history• Genetic testing: low yield even in familial
DCM (20-30%)• Promising future (?) with deep sequencing
![Page 49: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/49.jpg)
Myocarditis
Immune Response
DilatedCardiomyopathy
Virus
Genetics
![Page 50: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/50.jpg)
Clinical Presentation
Development of symptoms and signs of heart failure• Gradual symptoms or incidental finding• Progressive symptoms for periods varying
from weeks to months with acute HF due to intercurrent illnesses
• Aggressive, life-threatening fulminant heart failure (fulminant lymphocytic myocarditis, giant cell myocarditis)
![Page 51: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/51.jpg)
Prognosis in DCM
Average five-year mortality of ~20 percent
![Page 52: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/52.jpg)
Prognosis in DCM
Variable survival in patients with dilated cardiomyopathy depending on underlying etiologic basis
![Page 53: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/53.jpg)
Therapy in DCM
• Standard heart failure drug therapy Interventions: • Defibrillator• Biventricular pacingSurgery: • Heart transplantation• LV assist device
![Page 54: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/54.jpg)
Restrictive Cardiomyopathy(RCM)
![Page 55: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/55.jpg)
RCM - Pathophysiology
• Biatrial enlargement• Normal-sized ventricles • Marked interstitial fibrosis
• Increase ventricular wall stiffness
• abnormal diastolic function:• Myocardial fibrosis• Myocardial infiltration• Scarring of the endomyocard • Myocyte hypertrophy
• Impaired diastolic filling of the ventricle → heart failure
![Page 56: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/56.jpg)
Restrictive Cardiomyopathies
Noninfiltrative • Idiopathic cardiomyopathy (50%)* • Familial cardiomyopathy• Hypertrophic cardiomyopathy• Scleroderma• Pseudoxanthoma elasticum• Diabetic cardiomyopathy
Infiltrative • Amyloidosis * • Sarcoidosis * • Gaucher disease• Hurler disease• Fatty infiltration
Storage Disease • Hemochromatosis• Fabry disease• Glycogen storage disease
Endomyocardial• Endomyocardial fibrosis * • Hypereosinophilic syndrome• Carcinoid heart disease• Metastatic cancers• Radiation * • Anthracycline * • Drugs causing fibrous
endocarditis - serotonin, methysergide, ergotamine, mercurial agents, busulfan
![Page 57: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/57.jpg)
Symptoms and Signs• Fatigue, Dyspnea, Exercise intolerance• Right-sided congestive heart failure:
peripheral edema, hepatomegaly, ascites, and anasarca
• Physical examination:• elevated jugular venous pulse, • Kussmaul sign (rising JVP during inspiration)
• S3 and S4 gallops are common• apical pulse is palpable
• Signs and symptoms of systemic disease: amyloidosis, iron storage disease
![Page 58: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/58.jpg)
DifferentiateRestrictive CMP vs Constrictive Pericarditis
• Echocardiography• Cardiac Catheterization• Endomyocardial Biopsy for pathological
diagnosis• MRI (myocard), CT (pericard)
![Page 59: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/59.jpg)
Restrictive Physiology• Increased LV thickness and mass• Abnormal myocardium• Small LV size• Normal systolic function• Biatrial enlargement• Pericardial effusion
Mitral e’ velocities<5cm/sec
![Page 60: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/60.jpg)
DipPlateau
Hemodynamics of Restrictive Physiology
• Elevated left- and right-sided filling pressures• “Square root” sign in ventricular pressure recordings• LV-RV EDP diff>5mmHg • Respiratory LV-RV systolic "concordance“
![Page 61: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/61.jpg)
Prognosis in RCM
Prognosis is worse with infiltrative RCM particularly Amyloidosis
![Page 62: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/62.jpg)
Cardiac Amyloidosis Progressive infiltrative cardiomyopathy - twisted
beta-pleated sheet fibrils - grave prognosis
• Primary - AL protein plasma cell dyscrasias
30% cardiac involvement Chemo/Bone-marrow Tx
• Secondary AA protein less myocardial infiltration
• Familial Transthyretin autosomal dominant
25% significant cardiac involvement, conduction system Neurologic or renal involvement Liver Tx
• Senile ANP or transthyretin – variable infiltration
![Page 63: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/63.jpg)
Cardiac Amyloid
![Page 64: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/64.jpg)
Amyloidosis
• Restrictive Cardiomyopathy• Systolic Heart Failure – progressive disease• Orthostatic Hypotension - amyloid infiltration of the
autonomic nervous system
• Conduction System Disease - Sudden cardiac death: malignant arrhythmias or conduction block
![Page 65: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/65.jpg)
Arrhythmogenic Right Ventricular Cardiomyopathy
(ARVC)
![Page 66: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/66.jpg)
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
• Fibrofatty replacement of RV myocardium• 20% of SCD in young, in North Italy• Familial in >30% of pts
- autosomal dominant (clasical ARVC)- autosomal recessive (Naxos disease)
• Molecular mechanism:- apoptosis due to defective cellular junction (desmosome) and/or Calcium homeostasis - reprogrammed myocyte cell biology to a fibrofatty lineage
![Page 67: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/67.jpg)
Arrhythmogenic Right Ventricular Cardiomyopathy
Dx- structural, functional and electrophysiologic abnormalities, secondary to fibrofatty replacement of RV±LV myocytes
![Page 68: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/68.jpg)
Pathology of ARVD
Endomyocardial biopsy of RV from an affected family member; H&E stain; magnification x400. Replacement of myocytes with fatty and fibrous tissue is classic for ARVD.
Ahmad F, Roberts R, et al. Circulation 1998;98:2791
![Page 69: Cardiomyopathies Andre Keren, MD דר ' ישראל גוטסמן מערך הלב, הדסה עין כרם](https://reader036.vdocuments.us/reader036/viewer/2022062320/56649cf05503460f949c00ce/html5/thumbnails/69.jpg)
ARVD: NAXOS DISEASE
• Skin - palmar-plantar keratosis
• Woolly hair
Figure 1. A, WH as a feature of Naxos disease (non-African ancestry). B and C, Palmar and plantar keratoderma. Note clear demarcation at border with dorsal skin. D, Histopathological preparation of
palmar skin biopsy. Severe hyperkeratosis without epidermolysis.Coonar AS et al. Circulation 1998;97:2049